Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on August 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

ATORVASTATIN

Closed
SPE2DP-26-T-4605Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs Enterprise Procurement Office intends to issue Request for Proposal 36E79727R0039 for an unrestricted procurement of Latanoprost Ophthalmic Solution. This contract will establish an uninterrupted source of supply for the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The award will be granted to a single responsible offeror for a base period of one year with four pre-priced one-year option periods. The solicitation is expected to be issued in commercial item format per FAR Part 12 on approximately October 21, 2026, with a tentative closing date of November 4, 2026, under NAICS code 325412. Strict labeling and packaging requirements apply to this procurement. Offerors must provide the exact drug name as it appears on the label and a unique NDC number. The contractor's label must be the sole label on the product, and affixing labels over existing ones is prohibited; however, the label must allow VA labels to adhere securely on top. Additionally, vendors must comply with the American Academy of Ophthalmology’s recommended uniform color-coding system for the caps and labels of all topical ocular medications. This acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. All communications and submissions are to be handled electronically via SAM.gov, with James Sullivan serving as the primary point of contact.
Nac Pharmaceuticals (36E797)

POSTED

about 16 hours ago

DEADLINE

in 18 days
NAICS: 325412
New
Federal
6505--FY27 Lenalidomide BPA
Solicitation # 36C26227Q0083
The Department of Veterans Affairs, through Network Contracting Office 22, has issued this Sources Sought Notice and Request for Information to identify qualified sources for a Health Service Area 5.3 Blanket Purchase Agreement. The government seeks providers capable of supplying Lenalidomide medication in multiple dosage strengths, specifically 2.5mg, 5mg, 10mg, 15mg, 20mg, and 25mg oral capsules. The medication will be delivered to eight participating VA Medical Centers across Arizona, California, and New Mexico. Due to the nature of the medication, the contractor must hold Food and Drug Administration Risk Evaluation and Mitigation Strategy certification to dispense the product and must ensure strict adherence to handling, storage, and temperature control regulations to maintain medication integrity. This is not a formal solicitation, and responses are intended for market research and planning purposes to inform future acquisition decisions. The anticipated period of performance is one year from the date of award, with orders placed on an as-needed basis via approved purchase orders. Interested respondents must provide a comprehensive capabilities statement, business size status relative to NAICS 325412, and details regarding their status as a manufacturer or authorized distributor. Submissions must also address compliance with the Buy American Act, the Non-Manufacturer Rule, and limitations on subcontracting. All responses must be submitted via email to the designated contracting officer by November 12, 2026.
262-NETWORK Contract Office 22 (36C262)

POSTED

about 16 hours ago

DEADLINE

in 13 days

AI Contract Overview

Show more

This contract is for the procurement of Atorvastatin Calcium 40 mg tablets, supplied in bottles of 90 units. The order consists of 10 bottles under contract number SPE2DP-26-T-4605, with a required delivery date of August 13, 2026, and a delivery window of 5 days after order. The items must be stored at a controlled room temperature between 20 and 25 degrees Celsius and have a non-extendable shelf life of 24 months. The agreement mandates strict adherence to Medical Marking Standard No. 1 for labeling and marking, requiring the inclusion of the NSN, manufacturer, CAGE code, manufacture/expiration dates, and contract or lot numbers. Packaging must be commercial and capable of protecting the contents from damage, with delivery set as FOB Destination to the Carrier Outfitting Material Support Center in Suffolk, Virginia. The drug is FDA regulated, and the contract specifies that DLA Master List technical and quality requirements take precedence over other packaging standards.

General Info

Procurement of 10 bottles of Atorvastatin 40mg, delivery by August 13, 2026.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

6701 COLLEGE DRIVE, DOORWAY 71, SUFFOLK, VA, 23435-5000, USA

Set-Aside

NONE

Documents

1
PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
ATORVASTATIN
ATORVASTATIN CALCIUM TABLETS, 40 MG, 90S
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
. UNIT OF ISSUE BOTTLE 90'S. STORE AT CONTROLLED ROOM TEMPERATURE 20 #
25°C (68 # 77°F) [SEE USP].
1 BT = 90 EA
. LABELING AND MARKING MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD
NO. 1A DATED 4 FEBRUARY 2013. LABELS SHALL INCLUDE: NSN MANUFACTURER
AND CAGE DATE OF MANUFACTURE, EXPIRATION, OR RETEST DATE CONTRACT
NUMBER/LOT NUMBER.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. .
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-26-T-4605
SECTION B
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION
OF THE MEDICAL MARKING STANDARD NO. 1
https://www.dla.mil/Logistics-Operations/Packaging/
PFIZER INC 86491 P/N NDC00071-0157-23 DIXON-SHANE LLC 5J522 P/N NDC00071-0157-23 GREENSTONE LLC 48KC0 P/N NDC59762-0157-01 RADHA PHARMACEUTICALS INC 8PNH3 P/N NDC77771-0453-90
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017824348 0001 BT 10.000
NSN/MATERIAL:6505014598247
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N48253
CARRIER OUTFITTING MATL SUPPORT CTR
6701 COLLEGE DRIVE, DOORWAY 71
SUFFOLK VA 23435-5000
SPE2DP-26-T-4605
SECTION B
PR: 7017824348 PRLI: 0001 CONT’D
US
RDD 999/NMCS SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
N48253
CARRIER OUTFITTING MATL SUPPORT CTR
6701 COLLEGE DRIVE, DOORWAY 71
SUFFOLK VA 23435-5000
US
M/F: (TCN) N2341062125244
RDD: 999
PROJ: ZD8 TP 1
SUPP ADD: N48253 SIG: L
FOR GOVERNMENT USE ONLY: (IPD) 03
DIC: A4A DIST: X9B ADV: 2A FC: MQ
Need Ship Date:00/00/0000 Original Required Delivery Date:08/13/2026
SPE2DP-26-T-4605 NSN/Part Number: 6505-01-459-8247 Quantity: 10 BT Purchase Request: 7017824348QTY: 10 Delivery: 5 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS